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Abstract 
OBJECTIVE: Data on gastrointestinal diseases’ burden is 
incomplete, particularly in Southern European countries. The aim 
of this study was to estimate the burden of digestive diseases in 
Portugal.  
METHODS: Retrospective observational study based on the 
national hospitalizations database, identifying all consecutive 
episodes with a first diagnosis of a digestive disease between 2000 
and 2010, using ICD-9-CM codes. Comparative analyses were 
performed to assess hospitalization trends of major indicators over 
time and across regions. 
RESULTS: More than 75,000 deaths attributable to digestive 
diseases were observed, representing 16% of the overall in-hospital 
mortality. Over half of these (59%) were premature deaths (below 
75 years). Biliary-tract disease was the most common digestive 
disorder leading to hospitalization (249,817 episodes, 5,210 
episodes of acute stone-related cholecystitis in 2010 with 11% 
increase compared to 2000). Gastric cancer was responsible for the 
highest number of in-hospital deaths (10,278) and alcohol-related 
liver disorders accounted for the highest in-hospital premature 
deaths (7,572). Charges and in-hospital mortality rate for major 
digestive diseases both showed a significant positive relation with 
time progression (β=0.195, p<0.001), however, when adjusted for 
age, this was not significant. Significant positive associations were 
found between age and in-hospital mortality (odds ratio=1.032, 
p<0.001) and between charges and in-hospital mortality (odds 
ratio=1.054, p<0.001).
 vi 
 
CONCLUSION: In Portugal, digestive diseases represent an 
important burden with evidence of increasing trend. Ageing 
population strongly contributes to this increase, setting further 
demands on healthcare organizations. Diseases such as gastric 
cancer, biliary-tract disease and alcohol-related liver disorders may 
require particular attention.  
KEY WORDS: Digestive diseases, burden of illness, 
administrative data, mortality.
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Resumo 
INTRODUÇÃO: Existem poucos dados sobre o burden das 
doenças digestivas, nomeadamente em países sul-europeus. 
OBJECTIVOS: O objectivo deste estudo foi estimar o burden 
das doenças digestivas em Portugal.  
MÉTODOS: Estudo observacional retrospectivo com base no 
registo nacional de internamentos (base de dados GDH – ACSS), 
identificando todos os episódios consecutivos com diagnóstico 
principal correspondente a doença digestiva entre 2000 e 2010, 
usando os códigos ICD-9-CM. Foi feita uma análise comparativa 
para estudar as tendências dos internamentos ao longo do tempo e 
através das regiões geográficas. 
RESULTADOS: Foram observadas mais de 75,000 mortes 
atribuíveis a doenças digestivas, representando 16% da mortalidade 
global intra-hospitalar. Mais de metade destas (59%) foram mortes 
prematuras (abaixo dos 75 anos de idade). A doença do tracto 
biliar foi a condição que conduziu mais frequentemente a 
internamento (249,817 episódios, 5,210 episódios de colecistite 
aguda em 2010 com um aumento de 11% em relação a 2000). O 
cancro gástrico foi responsável pelo maior número de mortes 
intra-hospitalares (10,278) e a doença hepática alcoólica pelo maior 
número de mortes intra-hospitalares prematuras (7,572). Os custos 
e a taxa de mortalidade intra-hospitalar para as principais doenças 
digestivas mostraram uma relação positiva com a evolução 
temporal anual (β=0.195, p<0.001), no entanto após ajuste para a 
idade, esta relação não foi significativa. Foi encontrada associação 
positiva significativa entre a idade e a taxa de mortalidade intra-
 viii 
hospitalar (odds ratio= 1.032, p< 0.001) e entre os custos e a 
taxa de mortalidade intra-hospitalar (odds ratio= 1.054, p< 0.001). 
DISCUSSÃO: Em Portugal, as doenças digestivas representam 
um burden importante, com evidência de tendência crescente. O 
envelhecimento populacional contribui significativamente para este 
aumento, produzindo desafios adicionais no futuro da organização 
dos cuidados de saúde. Doenças como cancro gástrico, doença do 
tracto biliar e doença hepática alcoólica podem vir a requerer 
particular atenção. 
PALAVRAS CHAVE: Doenças digestivas, burden de doença, 
dados administrativos, mortalidade.
                                                                                   ix 
Preamble 
Medicine is a science of uncertainty and an art of probability. 
William Osler (1849–1919) 
 
 
A Medicina Interna é uma especialidade médica com vertente 
assistencial diversificada e complexa, mas também integradora e 
resolutiva. Exerce em diferentes sectores hospitalares e responde a 
estados variados de gravidade clínica. 
 
Desde cedo me prendeu a atenção o peso dos doentes hepáticos 
crónicos nas enfermarias hospitalares. Tantas vezes jovens, 
gravemente doentes, com internamentos prolongados e não 
raramente outcomes adversos. 
Foi esta observação que esteve na base do estudo da presente 
dissertação. 
 
 
 
Dessa observação até à presente dissertação vai um caminho feito 
de tempo, de conselhos, de trabalho em equipa, de contratempo, 
de escolhas, de perspectiva, de reestruturação. 
 
O conceito de burden of illness abrange vários aspectos relativos ao 
impacto das doenças nos indivíduos e nas populações – 
frequência, incidência e prevalência, mortalidade, mortalidade 
prematura, anos de vida perdidos, morbilidade, vivência com 
incapacidade, custos directos e indirectos.
x 
 
Este trabalho reflecte uma aproximação a esse conceito de burden, que se 
afigura como um conceito de grande utilidade e importância para a 
compreensão dos padrões de doença e sua evolução, e nomeadamente 
na resposta ao desafio que é a adaptação dos sistemas de saúde a esta 
evolução de padrões.
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1.  Introduction 
 
Digestive diseases (DD) have a great impact on population health 
and well-being. In the USA their global burden has been systematically 
assessed, representing high mortality (responsible for 10% of overall 
mortality in 2009[1]) and significant costs (142 millions of dollars in 
2004[2]).  There are other studies focusing on DD global impact in 
national health systems (USA, Eastern countries and UK)[1-8], with 
variation in measurements and reporting.  
In Europe, diarrhoeal diseases, hepatitis B and C, intestinal 
nematode infections, gastrointestinal (GI) cancer, liver cancer, pancreatic 
cancer and specific digestive diseases (peptic ulcer, liver cirrhosis, 
appendicitis) represented almost 30 million disability-adjusted life years 
(DALYs= years of life lost plus years lived with disability) in 2011, 
according to WHO[9]. Some studies addressed the burden of a group of 
digestive disorders in Europe (liver disease[10], GI and liver cancers[11],  
hepatitis C virus[12] and inflammatory bowel disease[13]). In southern 
European countries there are national reports highlighting 
epidemiological trends in specific group of digestive diseases such as 
upper gastrointestinal bleeding, gastro-oesophageal reflux, Barrett’s 
oesophagus, inflammatory bowel disease or celiac disease  (e.g.[14-22]), 
but only two studies addressed their global burden[23, 24]. 
Additionally, according to the latest WHO report on World Health 
Statistics[25], among the first listed diseases responsible for years of life 
lost (YLL) and premature mortality, two digestive disorders were 
identified: diarrhoeal diseases in 5th place and cirrhosis in 17th place. 
Studies addressing disease morbidity and mortality are important 
not only for clinicians and researchers, but also for health policy 
advising, leading to health care improvement.
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Despite limitations of working with administrative databases, with 
possible coding inaccuracies and limited clinical data, these databases can 
be used to study healthcare outcomes, monitor population health status 
and have the potential to contribute to quality development in 
healthcare[26-31]. These administrative databases are easily available, 
have a national coverage, are relatively inexpensive and can be useful for 
identifying long-term trends in hospital care, analysing quality and 
performance indicators, and studying the relation between 
hospitalizations and environmental determinants[32-34]. In Portugal, all 
hospitals of the National Health Service have this mutual national 
hospitalization database in use since 1990. 
Therefore, we aimed to study the global burden of digestive 
diseases in a Southern European country, by analysing associated 
hospitalizations, mortality and monetary costs.  
Material and Methods 18 
2. Material and Methods 
 
Study design and data source 
We conducted a retrospective observational study using data from the 
national hospitalizations database. This database, provided by the Central 
Administration of Health System of the Portuguese Ministry of Health 
(ACSS), gathers administrative and clinical data concerning 
hospitalization (in-patient and ambulatory surgery) episodes in National 
Health Service hospitals, notably diagnoses and procedures performed 
during hospital stay. Diagnosis and procedures are coded using the 
International Classification of Diseases - 9th Revision - Clinical 
Modification (ICD-9-CM). In Portugal, the ICD-9-CM based Diagnosis 
Related Group (DRG) prospective payment system is in use since 1990.  
 
Study population 
We studied all consecutive in-patient episodes in public hospitals 
between January 1st, 2000 and December 31st 2010 with a principal 
diagnosis corresponding to a digestive disease - any disorder affecting the 
alimentary tract and its associated organs: liver, gallbladder and pancreas. 
Data from private hospitals, representing around 15% of all inpatient 
stays in Portugal[29], was not available for inclusion in this study.  
Patients of all ages were considered and all consecutive episodes 
analyzed. Readmissions were considered as independent episodes.  The 
analysis of database information maintained patient anonymity.  
 
Data collection and variables estimate 
For each identified hospitalization episode, the following variables 
were analyzed: age, gender, length of stay (LOS), principal and secondary 
diagnoses (coded according to ICD-9-CM), discharge status (to compute
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 in-hospital mortality), mean monetary charges, type of admission, 
and discharge date.  
Because the list of ICD-9-CM codes is extensive, containing over 
14,000 diagnosis codes and 3,900 procedure codes, we used the Agency 
for Healthcare Research and Quality’s (AHRQ) Clinical Classification 
Software (CCS) to summarize ICD-9-CM codes into a small number of 
clinically meaningful groups[35].  
We selected all CCS categories corresponding to diagnostic entities of 
digestive diseases. Categories were screened and ICD-9-CM codes within 
each category reviewed, in order to avoid inclusion of non-digestive 
diseases or symptoms with probable association with other type of 
disorders. One CCS category was found to include only a limited 
number of digestive diagnoses, and so this specific category (CCS 663 
Screening and history of mental health and substance abuse codes) was 
partially adapted, comprising ICD-9-CM codes exclusively related to 
alcoholic digestive diseases. 
When studying contribution of specific diseases, some ICD-9-CM 
codes were selected and organized within groups in order to emphasize 
clinical and epidemiological relevant data.  
Healthcare costs for hospitalizations attributable to GI diseases were 
calculated according to the expenditure tables for NHS hospital 
reimbursements. The reimbursement is made according to the diagnosis-
related groups (DRGs) based budget allocation model. Expenditure 
tables are defined by governmental ordinance (in Diário da República).  
Demographic characteristics such as population size and its annual 
variations were obtained from the National Institute of Statistics (INE). 
 
Analysis  
Descriptive and inferential statistical analyses were performed using 
IBM SPSS Statistics v20TM (Statistical Package for Social Sciences).  
Analysis of mortality indicators included: in-hospital death (death 
during hospitalization episode), in-hospital premature death (death 
during hospitalization episode in patient having 75 years or less), PYLL 
(total potential years of life lost by population under age 75), in-hospital 
mortality rate (proportion of episodes with a particular condition with an 
outcome of death from that condition). Formulas as follows:
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 Hospitalization rate=  
       
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 ℎ𝑜𝑠𝑝𝑖𝑡𝑎𝑙𝑖𝑧𝑒𝑑 𝑓𝑜𝑟 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 𝑥
𝑡𝑜𝑡𝑎𝑙 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛
 × 100.000 
 
 
 In-hospital deaths for disease x (%)= 
      
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑑𝑦𝑖𝑛𝑔 𝑤𝑖𝑡ℎ 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 𝑥
𝑡𝑜𝑡𝑎𝑙 𝑜𝑓 ℎ𝑜𝑠𝑝𝑖𝑡𝑎𝑙𝑖𝑧𝑎𝑡𝑖𝑜𝑛𝑠 𝑤𝑖𝑡ℎ 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 𝑥
 × 100 
 
 
 In-hospital premature deaths for disease x (%)=         
                                                                 
       
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑑𝑦𝑖𝑛𝑔 𝑤𝑖𝑡ℎ 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 𝑥 𝑢𝑛𝑑𝑒𝑟 𝑡ℎ𝑒 𝑎𝑔𝑒 𝑜𝑓 75
𝑡𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑖𝑛ℎ𝑜𝑠𝑝𝑖𝑡𝑎𝑙 𝑑𝑒𝑎𝑡ℎ𝑠 𝑤𝑖𝑡ℎ 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 𝑥
 × 100 
 
 
 PYLL rate=  
 
       
𝑠𝑢𝑚 𝑜𝑓 𝑡ℎ𝑒 𝑡𝑜𝑡𝑎𝑙 𝑃𝑌𝐿𝐿 𝑜𝑓 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑤𝑖𝑡ℎ 𝑙𝑒𝑠𝑠 𝑡ℎ𝑎𝑛 75 𝑦𝑒𝑎𝑟𝑠 𝑑𝑦𝑖𝑛𝑔 𝑤𝑖𝑡ℎ 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 𝑥
𝑡𝑜𝑡𝑎𝑙 𝑜𝑓 ℎ𝑜𝑠𝑝𝑖𝑡𝑎𝑙𝑖𝑧𝑎𝑡𝑖𝑜𝑛𝑠 𝑤𝑖𝑡ℎ 𝑙𝑒𝑠𝑠 𝑡ℎ𝑎𝑛 75 𝑦𝑒𝑎𝑟𝑠
  × 100.000 = 
 
     =   
𝛴 (75 − 𝑎𝑔𝑒 𝑜𝑓 𝑑𝑒𝑎𝑡ℎ∗)
𝑡𝑜𝑡𝑎𝑙 𝑜𝑓 ℎ𝑜𝑠𝑝𝑖𝑡𝑎𝑙𝑖𝑧𝑎𝑡𝑖𝑜𝑛𝑠 𝑤𝑖𝑡ℎ 𝑙𝑒𝑠𝑠 𝑡ℎ𝑎𝑛 75 𝑦𝑒𝑎𝑟𝑠
 × 100.000   (* if death at age » 75, equals Ø) 
 
 
 
 
Comparative analysis of indicators in 2000 and 2010 was performed 
in order to assess changes over time. Chi-square test was used with a 
statistical significance level set at p< 0.05. Linear regression models were 
performed to assess trends in hospitalization rate, monetary charges and 
in-hospital mortality rate, studying their relationship with time 
progression. To adjust mean charges and in-hospital mortality rate for 
age, we included this last variable as independent variable. To understand 
the association between age, charges and in-hospital mortality we 
performed a logistic regression, using in-hospital mortality as dependent 
variable and the other two variables as independent. In all these 
regressions, charges were studied in millions of Euros.
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Geographic distribution of hospitalization rate (number of episodes 
per 100.000 inhabitants) and in-hospital mortality (with age-sex direct 
standardization of mortality for the 2011 Portuguese population) was 
made using the NUTS II and III classification for Portugal 
(Nomenclature of Units for Territorial Statistics levels II and III). 
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3. Results 
During the decade period 2000-2010, there were over 10.5 million 
registered hospitalizations in Portuguese public hospitals. Of these, we 
identified almost 1.5 million episodes with a principal diagnosis of a DD 
(13.8 % of total). 
 
CCS categories: outline of all digestive diseases 
An overview of all CCS categories that we have considered as 
digestive diseases is presented in Table 1, regarding frequency, age, LOS, 
costs and mortality.  
The most common diagnosis for in-hospital stay was biliary tract 
disease with almost 250,000 hospitalizations, followed by abdominal 
hernia and appendicitis/appendiceal conditions. Among the first ranked 
DD’s we also have pancreatic disorders, alcohol-related GI diseases and 
GI bleeding. 
The median LOS for patients with digestive diseases was 4 days, with 
the following disorders sharing the highest LOS (11 days): cancer 
(gastric, pancreatic, small intestine/gallbladder/peritoneal) and non-
malignant condition peritonitis/intestinal abscess.  
Patients with digestive congenital anomalies and intestinal infection 
presented with the lowest mean age, while patients with malignant 
conditions (colon, pancreatic, rectal/anal, small 
intestine/gallbladder/peritoneal and gastric cancers) and non-malignant 
disorders such as gastrointestinal hemorrhage and diverticular disease 
present with the highest age. 
Liver/intrahepatic bile duct cancer and gastric cancer were 
responsible for the highest mean monetary charges (7,168 € and 6,422 €, 
respectively). 
In terms of mortality, during this decade, digestive diseases were 
responsible for more than 75,000 in-hospital deaths, corresponding to 
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15.8% of the overall in-hospital mortality. More than half of these 
(59%) were premature deaths, leading to a PYLL rate of 49,663 per 
100,000 population under 75 years of age. 
The principal cause of in-hospital deaths among patients with 
digestive diseases was gastric cancer with more than 10,000 losses during 
this decade. For patients dying prematurely, the leading cause was 
alcoholic-related liver disease, responsible for more than 7,500 deaths.  
Comparing indicators in digestive conditions versus the sum of all 
clinical conditions, we observe that the mean age is slightly higher in 
patients presenting with digestive diseases (53.3 ± 24.4 vs 46.1 ± 28 yrs), 
the mean monetary charges are more elevated (3.157 vs 2.494 EUR) and 
in-hospital mortality rate, in-hospital premature deaths and rate of 
PYLL’s are all higher (5.17% vs 4.51%, 58.7% vs 46.2%, 49,663 vs 
36,905) in DD’s when compared with the total of all diseases. 
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Table 1: Gastrointestinal and Hepatology Principal Discharge Diagnoses for Hospitalizations, using CCS, 2000-2010 (only inpatient data) 
 
Rank 
among 
GI dx 
Rank 
among 
all dx 
Single-Level CCS principal diagnosis code and 
category 
Total No. 
discharges 
Median LOS 
(days) 
Mean age 
(SD) 
Mean charges 
(EUR) 
In-hospital 
deaths, n (%) 
In-hospital premature 
deaths, n (%) 
Rate of 
PYLL[75] 
1 5 149 - Biliary tract disease 249,817 4 60.8 (17.2) 2,447 3,673 (1.47) 1,137 (31.0) 5,421 
2 6 143 - Abdominal hernia 240,472 2 55.5 (20.7) 2,157 1,466 (0.61) 481 (32.8) 2,258 
3 16 142 - Appendicitis and other appendiceal conditions 121,917 3 28.3 (19.0) 2,257 302 (0.25) 126 (41.7) 1,174 
4 43 152 - Pancreatic disorders (not diabetes) 66,128 7 61.2 (18.5) 3,036 3,045 (4.60) 1,388 (45.6)      39,395 
5 44 663 partial - considering only related GI diseases 
ICD-9-CM codes: 535.3x, 571.0, 571.1, 571.2, 571.3 
(alcoholic gastritis and alcoholic related liver disorders ) 
63,351 8 57.5 (12.4) 5,439 8,751 (13.8) 7,572 (86.5)      222,282 
6 48 153 - Gastrointestinal hemorrhage 59,753 6 66.9 (18.7) 2,921 4,625 (7.74) 1,652 (35.7)       54,325 
7 51 135 - Intestinal infection 57,409 3 21.7 (29.8) 1,424 777 (1.35) 213 (27.4) 4,259 
8 52 14 - Colon cancer 57,024 10 69.2 (12.0) 6,129 8,949 (15.69) 4,995 (55.8)     140,985 
9 54 154 - Noninfectious gastroenteritis 53,442 2 21.9 (30.1) 1,260 624 (1.17) 167 (26.8) 4,119 
10 61 13 - Gastric cancer 47,331 11 67.8 (13.1) 6,422 10,278 (21.72) 6,333 (61.6)      252,763 
11 67 147 - Anal and rectal conditions 44,564 2 48.5 (17.4) 2,230 209 (0.47) 110 (52.6)       3,051 
12 68 145 - Intestinal obstruction without hernia 44,519 6 63.1 (21.9) 3,163 3,422 (7.69) 1,433 (41.9)       58,742 
13 70 15 - Rectal and anal cancer 41,735 10 68.5 (12.1) 5,890 5,097 (12.21) 3,038 (59.6)     121,063 
14 86 151 - Other liver diseases 34,776 6 57.9 (17.4) 5,569 3,988 (11.47) 3,055 (76.6)     173,510 
15 91 155 - Other gastrointestinal disorders 32,895 6 54.7 (25.8) 3,549 1,444 (4.39) 712 (49.3)      36,100 
16 106 120 - Hemorrhoids 25,965 2 51.5 (14.4) 2,172 24 (0.09) 16 (66.7) 719 
17 107 146 - Diverticulosis and diverticulitis 25,631 7 66.1 (15.1) 2,905 640 (2.50) 149 (23.3) 6,141 
18 123 138 - Oesophageal disorders 19,899 4 48.1 (30.4) 3,047 406 (2.04) 196 (48.3)      18,394 
19 126 251 - Abdominal pain 19,481 2 41.4 (26.8) 1,171 306 (1.57) 107 (35.0)       8,246 
20 132 141 - Other disorders of stomach and duodenum 18,706 2 28.1 (31.8) 2,109 346 (1.85) 167 (48.3)      11,326 
21 137 6 - Hepatitis 18,415 2 44.1 (18.4) 3,502 400 (2.17) 291 (72.8)      30,991 
22 140 144 - Regional enteritis and ulcerative colitis 17,470 8 39.7 (18.1) 3,272 195 (1.12) 119 (61.0)     13,074 
23 143 17 - Pancreatic cancer 17,109 11 68.8 (12.5) 5,161 4,931 (28.82) 3,054 (61.9)     298,525 
24 152 18 - Other GI organs and peritoneal cancer 15,257 11 68.0 (14.4) 5,350 3,207 (21.02) 1,864 (58.1)     212,684 
25 154 140 - Gastritis and duodenitis 14,921 5 61.1 (25.1) 2,454 347 (2.33) 106 (30.5)      13,130 
26 158 139 - Gastroduodenal ulcer (except hemorrhage) 14,051 8 60.8 (19.0) 6,137 1,063 (7.57) 422 (39.7)      47,475 
27 164 16 - Liver and intrahepatic bile duct cancer 12,988 7 64.9 (14.1) 7,168 3,301 (25.42) 2,424 (73.4)     300,681 
28 173 12 - Osophageal cancer 11,912 9 63.2 (12.3) 5,049 2,596 (21.79) 2,065 (79.5)     319,925 
29 207 148 - Peritonitis and intestinal abscess 6,569 11 57.0 (18.9) 4,679 1,002 (15.25) 660 (65.9)     187,615 
30 212 214 - Digestive congenital anomalies 5,895 4 11.1 (21.4) 5,400 52 (0.88) 45 (86.5)      45,342 
  Total digestive diseases 1,459,402 4 53.3 (24.4) 3,157 75,466 (5.17) 44,265 (58.7)      49,663 
  Total diseases 10,586,118 4 46.1 (28.0) 2,494 477,702 (4.51) 220,623 (46.2)      36,905 
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Major digestive disorders: trends over time 
Table 2 shows the five main groups of digestive diseases, according to 
organ or type of disorder: biliopancreatic, liver, cancers, inflammatory 
bowel disease and GI infections. The contribution of each group is 
represented, as well as comparison of indicators over time.  
Selected diseases within these five groups represent 4.7 % of the 
overall hospitalizations in 2010 (42,719 episodes). 
Within the group of patients presenting with biliopancreatic diseases, 
acute pancreatitis accounts for the highest rate of hospitalization (53.9 
hospitalizations per 100.000 inhabitants). Comparative changes between 
2000 and 2010 regarding total number of hospitalizations show that 
cholangitis is responsible for the highest increase (178.8%, p< 0.001) and 
chronic pancreatitis for the highest decrease (-19.8%, p= 0.023). In-
hospital deaths were higher in 2010 for acute conditions (cholelithiasis 
with acute cholecystitis, cholangitis and acute pancreatitis), when 
compared to 2000, although with no significant statistical difference. 
Concerning patients with liver diseases, alcohol-related disorders 
show the leading rate of hospitalization, while viral hepatitis B and C 
show an important decline (-65.1% and -57.1% respectively, p < 0.001). 
Cirrhosis-related complications (hepatic encephalopathy, portal 
hypertension, ascites, oesophageal varices rupture, spontaneous bacterial 
peritonitis, hepatorenal and hepatopulmonary syndromes) were not only 
responsible for an increase of 41.3% in hospitalizations over the decade 
(p< 0.001), but for the highest in-hospital mortality rate within this 
group both in 2000 and in 2010 (14.4% and 16.8% respectively).  The 
liver diseases group was the only one of digestive diseases in which in-
hospital mortality rate increased across all disorders, and it is the most 
frequent secondary-diagnosis (total 22,901 episodes).  
Digestive cancers show a global increase in hospitalization rates 
except for oesophageal (-14.7%, p= 0.008), gastric (-9.7%, p= 0.006) and 
rectal/anal cancers (-5.6%, p< 0.001). All the others have increasing 
hospitalization rates over the decade, led by liver and intra-hepatic bile 
duct cancer (91.2% increase, p< 0.001). The main causes of in-hospital 
deaths and in-hospital mortality rates among digestive diseases belong to 
this group (pancreas, stomach, colon, gallbladder and extra-hepatic bile 
ducts, oesophagus, liver and intra-hepatic bile duct). Regarding evolution 
of mortality indicators within this group, we observe that three 
conditions presented a decline in hospital mortality rates, despite having 
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higher number of hospitalizations: liver and intrahepatic bile duct 
cancer, small intestine cancer and retroperitoneal/peritoneal cancer. In 
2010, all other digestive cancers presented higher in-hospital mortality 
rates than in 2000. 
With regards to inflammatory bowel disease (IBD), there has been a 
much larger increase in the rate of hospitalizations per 100,000 
population rate for Crohn’s disease than ulcerative colitis (UC) (30.1% vs 
9.6%, with p= 0.029) . UC has shown a decrease in mortality indicators, 
notably in-hospital mortality rate changed from 3.1 in 2000 to 0.4 in 
2010 (p= 0.001), which was not observed in Crohn’s disease. 
For the last group, patients with GI infections, all disorders show a 
statistical significant declining trend in hospitalization rates, with more 
pronounced decline in food born infections (-94.6%), followed by 
atypical infections like cholera, typhoid fever and amebiasis (-75.2%). 
Despite this decline, in-hospital deaths, as well as in-hospital mortality 
rate, were higher in 2010 when compared with 2000 for infectious colitis, 
enteritis and gastroenteritis (24 in-hospital deaths and 0.9% of in-hospital 
mortality rate in 2000 vs 75 and 3.2% in 2010, p< 0.001). 
Overall, for the five considered main groups of digestive diseases, 
hospitalization rates increased 4.3% (p< 0.001). Median LOS decreased 
for all listed disorders except for non-alcoholic fatty liver disease 
(NAFLD), colitis/enteritis/gastroenteritis of infectious origin and GI 
food born infections. Total monetary charges increased (global 17.2%) 
except for chronic pancreatitis, viral hepatitis B and C, NAFLD, 
oesophageal and gastric cancer, and almost all GI infections. The most 
substantial increases in total charges were attributable to cholangitis 
(202.0%) and liver/intrahepatic bile duct cancer (119.5%); most 
significant decrease was observed in food born GI infections (-93.0%) 
and viral hepatitis B (-70.2%). 
Number of in-hospital deaths increased from 4,265 in 2000 to 5,239 
in 2010, and also in-hospital mortality rate rose from 10.4% in 2000 to 
12.3% in 2010 (p< 0.001). 
Mean age of hospitalized patients rose from 57.5 years in 2000 to 62.4 
years in 2010.
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To complement these results and more accurately predict the 
relationship between indicators and time, we used linear regression 
models to assess trends concerning three key indicators: hospitalization 
rates, monetary charges and in-hospital mortality rates. Table 3 includes 
all detailed annual data. Hospitalization rates show no significant relation 
with time (β=0.155, p= 0.870). In-hospital mortality rate showed a 
significant positive relation with time progression (while monetary 
charges and in-hospital mortality rate both show an important relation 
(β=0.195, p<0.001). However, when adjusted for age, this relation was 
not significant (discharge year: β=0.152, p= 0.141; age: β=0.089, p= 
0.649). Mean monetary charges also showed a significant positive 
relation with time progression (β=0.058, p<0.001). However, when 
adjusted for age, this relation was not significant (β=0.024, p= 0.064). In 
this linear regression, age showed a significant positive relation with 
mean monetary charges (β=0.071, p= 0.014), even when adjusted for 
time progression. 
Significant positive associations were found between age and in-
hospital mortality (odds ratio=1.032, p<0.001) and between monetary 
charges and in-hospital mortality (odds ratio=1.054, p<0.001). 
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Table 2 – Gastrointestinal and Hepatology Selected Discharge Diagnoses for Hospitalizations in 2010 (only inpatient data) 
 
Principal diagnosis  Total nr. 
discharges in 
2010 
Total nr. 
discharges 
per 100.000 
inhabitants 
% Change 
from 2000 
(p-value *) 
Median 
LOS 
(days), 
2010 
(2000) 
 % Total hospital 
days within all 
hospitalizations 
** 
Total charges 
(EUR, 
millions) 
% 
Change 
from 
2000 
In-
hospital 
deaths in 
2010, n 
(%) 
In- 
hospital 
deaths in 
2000, n  
(%) 
p-value 
(*) 
% Planned 
admissions, 
2010 
(2000) 
Mean age, 
2010 
(2000) 
Total nr. 
discharges as a 
secondary 
diagnosis*** 
Biliopancreatic diseases 
Cholelithiasis  with acute 
cholecystitis 
5,210 51.8 11.2 
(< 0.001) 
7.0 
(7.0) 
 0.667 
14,146 17.4 
151 (2.9) 111 (2.4) 0.101 7.2 (10.0) 65.8 (63.8) 529 
Cholangitis 1,263 12.6 178.8 
(< 0.001) 
8.0 
(8.0) 
 0.199 
4,222 202.0 
78 (6.2) 25 (5.5) 0.614 8.6 (15.9) 69.6 (65.7) 1,037 
Acute pancreatitis 5,426 53.9 13.3 
(< 0.001) 
7.0 
(8.0) 
 0.803 
16,305 14.9 
250 (4.6) 219 (4.6) 0.932 2.1 (2.6) 62.9 (60.5) 1,010 
Chronic pancreatitis 296 2.9 -19.8 
(0.023) 
6.0 
(7.0) 
 0.037 
982 -14.6 
5 (1.7) 7 (1.9) 0.841 25.7 (31.2) 54.9 (49.4) 458 
Cyst and pseudocyst of 
pancreas 
212 2.1 15.8 
(0.059) 
7.0 
(13.0) 
 0.034 
916 2.5 
3 (1.4) 13 (7.1) 0.004 53.3 (36.6) 56.6 (55.5) 321 
Liver diseases 
Viral hepatitis B 185 1.8 -65.1 
(< 0.001) 
1.0 
(6.0) 
 0.018 
644 -70.2 
4 (2.2) 5 (0.9) 0.200 51.4 (30.9) 43.7 (37.5) 1,487 
Viral hepatitis C 359 3.6 -57.1 
(< 0.001) 
1.0 
(1.0) 
 0.028 
2,106 -16.1 
10 (2.8) 3 (0.4) < 0.001 53.8 (67.5) 48.6 (37.7) 4,222 
Alcohol-related liver 
diseases 
4,711 46.8 -17.7 
(< 0.001) 
7.0 
(9.0) 
 0.739 
28,543 2.6 
714 
(15.2) 
744 (13) 0.002 15.0 (11.1) 58.6 (56.8) 6,069 
NAFLD 188 1.9 -20.7 
(0.005) 
3.0 
(2.0) 
 0.017 
678 -13.2 
12 (6.4) 9 (3.8) 0.222 43.9 (57.0) 55.7 (49.9) 2,672 
Cirrhosis-related 
complications 
1,164 11.6 41.3 
(< 0.001) 
7.0 
(7.0) 
 0.166 
4,742 44.3 
196 
(16.8) 
119 (14.4) 0.149 5.8 (12.0) 60.6 (56.9) 8,451 
Digestive cancers 
Oesophageal cancer 965 9.6 -14.7 
(0.008) 
8.0 
(10.0) 
 0.188 
5,078 -9.9 
216 
(22.4) 
214 (18.9) 0.050 43.1 (49.4) 62.8 (63.2) 766 
Gastric cancer 3,999 39.8 -9.7 
(0.006) 
10.0 
(12.0) 
 0.851 
26,313 -3.8 
926 
(23.2) 
865 (19.5) < 0.001 48.8 (43.3) 68.7 (67.1) 1,594 
Colon cancer 5,677 56.4 31.8 
(< 0.001) 
10.0 
(11.0) 
 1.113 
35,979 43.1 
895 
(15.8) 
636 (14.8) 0.172 52.5 (44.0) 70.1 (68.0) 1,974 
Rectal and anal cancer 3,569 35.5 -5.6 
(0.546) 
10.0 
(11.0) 
 0.737 
22,007 5.7 
474 
(13.3) 
421 (11.1) 0.005 62.6 (58.7) 69.0 (67.6) 1,384 
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Liver and intrahepatic bile 
duct cancer 
1,748 17.4 91.2 
(< 0.001) 
5.0 
(9.0) 
 0.239 
12,773 119.5 
380 
(21.7) 
243 (26.6) 0.005 50.9 (32.9) 64.8 (62.5) 637 
Gallbladder /extra-hepatic 
bile ducts cancer 
972 9.7 21.0 
(0.002) 
11.0 
(14.0) 
 0.222 
5,300 28.7 
220 
(22.6) 
160 (19.9) 0.166 30.8 (27.0) 71.6 (69.2) 303 
Pancreatic cancer 1,816 18.1 32.9 
(< 0.001) 
10.0 
(12.0) 
 0.355 
9,456 37.4 
530 
(29.2) 
353 (25.8) 0.037 31.9 (27.7) 69.4 (67.8) 554 
Small intestine cancer 235 2.3 41.6 
(< 0.001) 
10.0 
(13.5) 
 0.053 
1,479 52.8 
44 (18.7) 32 (19.3) 0.889 41.7 (37.3) 65.9 (63.7) 82 
Retroperitoneal and 
peritoneal cancer 
246 2.4 15.5 
(0.045) 
8.0 
(10.0) 
 0.049 
1,387 44.0 
42 (17.1) 39 (18.3) 0.729 62.6 (52.6) 61.4 (58.1) 155 
Inflammatory bowel disease 
Chron’s disease / 
granulomatous enteritis 
1,189 11.8 30.1 
(< 0.001) 
7.0 
(7.0) 
 0.175 
4,168 45.8 
8 (0.7) 5 (0.5) 0.715 27.0 (36.7) 37.3 (37.0) 957 
Ulcerative colitis 492 4.9 9.6 
(0.039) 
8.0 
(11.0) 
 0.085 
1,422 3.7 
2 (0.4) 14 (3.1) 0.001 23.0 (27.4) 45.1 (46.6) 572 
GI infections 
Colitis, enteritis and 
gastroenteritis of infectious 
origin 
2,379 23.7 -12.2 
(0.002) 
3.0 
(2.0) 
 0.167 
3,825 11.1 
75 (3.2) 24 (0.9) < 0.001 1.3 (1.1) 35.6 (20.8) 735 
Salmonella gastroenteritis 226 2.2 -51.1 
(< 0.001) 
5.0 
(5.0) 
 0.022 
439 -42.4 
1 (0.4) 1 (0.2) 0.605 5.3 (1.1) 26.3 (14.3) 38 
Bacterial enteritis 146 1.5 -52.0 
(< 0.001) 
3.0 
(3.0) 
 0.010 
231 -43.8 
1 (0.7) 1 (0.3) 0.595 0.7 (0.0) 23.2 (7.0) 21 
Atypical (cholera, typhoid 
fever, amebiasis, other 
protozoal) 
32 0.3 -75.2 
(< 0.001) 
6.0 
(8.0) 
 0.004 
91 -61.6 
1 (3.1) 2 (1.6) 0.555 6.3 (4.7) 36.5 (36.6) 54 
Food born 14 0.1 -94.6 
(< 0.001) 
4.5 
(2.0) 
 0.001 
27 -93.0 
1 (7.1) 0 (0) < 0.001 0.0 (0.8) 46.0 (19.1) 13 
Total 
42,719 424.7 4.3 
(< 0.001) 
8.0 
(8.0) 
 6.980 203,260 17.2 5239 
(12.3) 
4,265 (10.4)     < 0.001 28.1 (25.9) 62.4 (57.5) 23,323 
 
 
* Pearson chi-square test 
** All hospitalizations corresponds to 909,380 episodes  
*** excluding episodes with such a code in the principal diagnosis 
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Table 3 - Hospitalization rate, in-hospital mortality rate and total charges for major digestive 
diseases in Portugal from 2000 to 2010. 
 
 
 
Year 
Hospitalization rate (per 
100,000 inhabitants) 
In-hospital mortality rate 
(%) 
Total charges 
(€, millions) 
2000 416 10.4 173.40 
2001 430 10.9 181.17 
2002 427 11.1 185.85 
2003 438 10.7 191.96 
2004 441 11.1 194.65 
2005 441 11.4 196.50 
2006 438 11.6 198.49 
2007 438 12.0 202.21 
2008 436 12.2 206.23 
2009 417 12.4 201.49 
2010 425 12.3 203.25 
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Geographical variations 
Figure 1 shows the geographic distribution of hospitalization rate 
(number of episodes per 100,000 inhabitants) and in-hospital mortality 
rate (number of deaths per total of hospitalizations) in 2000 and 2010 for 
all digestive diseases. Tâmega, Alentejo Litoral and Entre Douro e Vouga 
were the 3 regions with the lowest hospitalization rates both in 2000 and 
2010. North interior comprised regions with the highest rates of 
hospitalization. In-hospital mortality rate was higher in Algarve in 2000, 
but in contrast North and Alentejo presented with higher in-hospital 
mortality rates in 2010.  
 
 
 
 
 
 
 
Figure 1: Geographical distribution of hospitalization rate (number of episodes per 100,000 
inhabitants) and in-hospital mortality (%) for major digestive diseases, in Portugal, from 2000-
2010. 
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4. Discussion 
Key evidence – analyzing main findings  
Studies reporting the incidence, prevalence and mortality of specific 
digestive diseases in particular regions or countries are often published. 
Also, in times of overt financial constraints, studies on economic impact 
of diseases are increasingly more frequent. However, studies assessing 
the global impact of digestive diseases in individuals, society and health 
systems are scarce, as well as reports on its variations and trends[8]. 
Other studies on this subject have been discussed already[1, 2, 3, 5, 6], 
coming mostly from USA and less from Europe[8, 23, 24], both 
including data from outpatient visits and inpatient hospital admissions. 
In southern European countries there is particular need of reporting, 
because of the lack of studies addressing this subject[23, 24]. 
The growing burden of digestive diseases observed in our study is 
consistent with the findings in these other reports, however the trends in 
specific disorders are somewhat different. 
In the UK, conditions such as hepatitis C infection, acute and chronic 
pancreatitis, alcoholic liver disease, gallstone disease, upper 
gastrointestinal haemorrhage, diverticular disease, Barrett’s oesophagus, 
and oesophageal and colorectal cancers are drawing attention for 
increasing incidence and thus future implications[8]. In USA, 
gastroesophageal reflux, acute pancreatitis, colorectal cancer and 
clostridium difficile infections are the leading reasons for concern according 
to Peery et al[1]. Everhart et al[2] highlighted digestive cancers and liver 
diseases as leading causes of mortality, and again liver diseases as a major 
contributor of years of potential life lost (YPLL). 
In Portugal, there are studies assessing the impact of specific digestive 
disorders: Marinho et al [36] addressed the rising costs and hospital 
admissions for hepatocellular carcinoma; and Cortez-Pinto et al [37] 
studied the burden and costs of diseases attributable to alcohol drinking.
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 Two other Portuguese studies evaluated the impact of liver diseases 
in hospitalization setting [38, 39]. Also Ramalho et al [40] and Antunes et 
al[22] studied the incidence and prevalence of celiac disease among 
pediatric Portuguese population.  
In our study, we found evidence that digestive diseases represent an 
important and increasing burden for individuals, institutions and 
healthcare national service thus placing high demands in the future for 
healthcare organization. Globally, we found that the number of 
hospitalizations due to digestive diseases is increasing, older patients are 
being admitted, with higher costs and also higher mortality rates, what is 
significantly related to ageing of the population. Despite variability in 
hospitalization rate across the decade, with an increasing trend in the 
first five years followed by a decreasing trend afterwards, trends in 
charges and in-hospital mortality are showing unequivocal rising burden.  
When adjusted to age, there were no significant changes through the 
decade both for monetary charges and for in-hospital mortality rates, 
what highlights the ageing of the population as a major contributor to 
trends in hospitalization indicators. Incidence and/or prevalence of 
many digestive diseases peak at older ages, and so it is likely that 
extended life expectancy will lead to future higher burden. 
Although digestive diseases responsible for the largest number of 
hospitalizations are non-malignant diseases such as acute biliopancreatic 
disorders, digestive cancers still represent a major burden in 
hospitalization days, costs and mortality indicators, with a rising global 
trend profile. Upper and lower GI cancers contribute similarly to 
mortality (number of deaths), as opposed to USA where lower GI 
cancers are alone the first cause of digestive mortality[2]. 
Gastric cancer, known for high incidence and mortality in 
Portugal[41, 42, 43], often diagnosed in advanced stages of disease, 
requires special attention: although with a slight decrease in 
hospitalization rate over the decade, it still presents with the greatest 
number of in-hospital deaths of all digestive disorders. 
Liver diseases, notably alcohol-related disorders and cirrhosis-related 
complications, are the principal cause of mortality in patients bellow 75 
years old, representing therefore a crucial subject for future 
improvements. This is particularly important because the latest WHO 
report on health statistics demonstrates that Portugal is listed among the 
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countries with highest harmful consumption of alcohol worldwide[25, 
39]. 
Biliary tract disease is a condition consuming great amount of 
healthcare resources given the number of hospitalization episodes, but 
with relatively low mortality. This finding is consistent with other 
reports[1, 2, 8, 44]. A likely explanation for this is again the ageing of the 
population, as well as the increasing prevalence of other risk factors such 
as obesity and diabetes. 
Hospitalization for GI infections in the era of antibiotics misuse and 
widespread resistances poses an important concern. Even though the 
number of hospitalizations has decreased during the decade, mortality 
has increased, and so additional efforts in understanding the factors 
contribution to this trend might be of interest. 
 
Assets and limitations of the study 
Information collected using a database with national coverage allows 
reporting of burden of disease on a nationwide basis, strengthening the 
validity and credibility of the research. However, these depend largely on 
accuracy of diagnosis and procedures coding. Several studies have 
addressed this subject, studying the suitability of ICD coding in clinical 
research, finding them valid and accurate for several digestive 
diseases[31, 45, 46, 47], although in some reports combined databases or 
code combination are advised[48, 49, 50, 51]. 
A major strength of this study is reporting data on healthcare resource 
use and disease mortality over a time period of the decade 2000-2010, 
potentially serving as a valuable instrument for the current scrutiny and 
debate concerning the Portuguese healthcare service. We think these 
findings are representative of the Portuguese burden of digestive disease, 
but in addition may be of use in other European countries with similar 
healthcare organization, and current economic and social characteristics. 
Some limitations to the present study should however be pointed out. 
Even though this study represents the totality of inpatient stays from 
public hospitals in Portugal, these represent 85% of all hospitalizations 
episodes, and so the real burden of digestive disease may be 
underestimated by missing the 15% inpatient episodes from private 
hospitals. We believe missing data from private hospitals could have 
further strengthened our findings. We were also not able to access 
healthcare indicators from primary care, urgent care or medication
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 consumption and costs, which might have contributed to 
underscoring the real growing burden of digestive diseases. Limitations 
on the use of ICD-9-CM coding are also noteworthy of mention, since 
underreporting is not so rare.  
 
Challenges and opportunities for the future 
In Portugal this health problem represents an important and 
increasing burden for individuals, institutions and healthcare national 
service thus placing high demands in the upcoming of healthcare 
organization. Our findings may be valuable to promote a wide reflection 
on the attention given to digestive diseases, from a broad range 
perspective and including several levels of care. Increasingly aged 
population, high prevalence of metabolic syndrome and persisting 
drinking habits are elements that anticipate no improvement in this 
disease burden. Particular diseases such as gastric cancer, biliary-tract 
disease and alcohol-related liver disorders should require special 
attention.  
Proposed strategies for the future are: focus on information and 
prevention leading to risk reduction and patient engagement and also 
focus on improvement of palliative and end of life care. Transferring a 
part of care from classical hospitalization setting to ambulatory care 
setting, optimizing and maximizing resources such as day-hospital or 
minimal invasive procedures is already established in some Portuguese 
hospitals. Another challenging urgent investment in a rapidly ageing 
country like Portugal is the promotion of healthy ageing through political 
and social approaches leading to more active and healthy elderlies and 
making health and social services accessible, affordable and efficient 
particularly for them.  
Future research on topics like health related quality of life, 
improvement of hospitalization outcomes, service planning and disease 
registries are likely to produce valuable information with future high 
applicability.   
This reflection is of importance for decision makers, clinicians, 
researchers, payers and other stakeholders regarding resource allocation 
on future approaches and might represent a breakthrough in research, 
raising challenging new questions and possibilities. 
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5. Conclusion 
In summary, we have demonstrated that digestive diseases represent 
an important burden in a southern European country such as Portugal, 
region where data on this subject are still lacking. This burden shows to 
be rising, as revealed through comparative analysis of indicators over the 
last decade, trends which are strongly related to ageing population. We 
found there are diseases source of particular concern, justifying a 
comprehensive close up in order to understand how to develop 
resources to improve outcomes. We expect that our research could be a 
cornerstone to a wide reflection on digestive diseases management, 
promoting multidisciplinary dialogue and effort. 
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